Editas Medicine, Inc. (EDIT)
2.66
+0.02
(+0.57%)
USD |
NASDAQ |
Jun 09, 16:00
2.62
-0.04
(-1.50%)
After-Hours: 20:00
Editas Medicine SG&A Expense (Quarterly) : 10.23M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Precision BioSciences, Inc. | 6.803M |
| Black Diamond Therapeutics, Inc. | 4.256M |
| Agenus, Inc. | 6.86M |
| Amgen, Inc. | 1.602B |
| BioCryst Pharmaceuticals, Inc. | 94.55M |